Variant report
Variant | nsv435764 |
---|---|
Chromosome Location | chr3:89509118-89518242 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs550109371 | chr3:89509125-89509126 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs551048671 | chr3:89509134-89509135 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs569291840 | chr3:89509163-89509164 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs568354437 | chr3:89509172-89509173 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs186970345 | chr3:89509195-89509196 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs34819360 | chr3:89509229-89509230 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs150353807 | chr3:89509242-89509243 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs77197588 | chr3:89509294-89509295 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs539614439 | chr3:89509308-89509309 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs190413320 | chr3:89509338-89509339 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs181307892 | chr3:89509364-89509365 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs543140504 | chr3:89509378-89509379 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs185329876 | chr3:89509404-89509405 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs573533395 | chr3:89509416-89509417 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs558335596 | chr3:89509488-89509489 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs138064258 | chr3:89509503-89509504 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs573498855 | chr3:89509532-89509533 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs112087049 | chr3:89509550-89509551 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs556124792 | chr3:89509556-89509557 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs143732498 | chr3:89509574-89509575 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs564350485 | chr3:89509579-89509580 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs80352065 | chr3:89509580-89509581 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs189796646 | chr3:89509591-89509592 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs550003745 | chr3:89509592-89509593 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs568570036 | chr3:89509612-89509613 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs541503446 | chr3:89509626-89509627 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs535447265 | chr3:89509705-89509706 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs547834356 | chr3:89509765-89509766 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs565933807 | chr3:89509773-89509774 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs539751755 | chr3:89509861-89509862 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs558123214 | chr3:89509862-89509863 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs576150966 | chr3:89509919-89509920 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs537276618 | chr3:89509934-89509935 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs182353666 | chr3:89509945-89509946 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs555156144 | chr3:89509966-89509967 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs369572746 | chr3:89509974-89509975 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs201843797 | chr3:89510073-89510074 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs386663326 | chr3:89510080-89510081 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs570269167 | chr3:89510081-89510082 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs375199255 | chr3:89510125-89510126 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs3860568 | chr3:89510128-89510129 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs7647741 | chr3:89510238-89510239 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs201105456 | chr3:89510590-89510591 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs9637529 | chr3:89511229-89511230 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs7433780 | chr3:89511231-89511232 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs9637530 | chr3:89511250-89511251 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs9637531 | chr3:89511293-89511294 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs573698709 | chr3:89511349-89511350 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs7427734 | chr3:89511386-89511387 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs9637532 | chr3:89511667-89511668 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21183584 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Cervical cancer | 21062161 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Breast cancer | 22032731 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Wilms tumour | 21544195 | CNVD |
Soft tissue tumor | 16732325 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
craniofacial dysmorphism | 21918468 | CNVD |
Cancer | 20164920 | CNVD |
Lung cancer | 19547694 | CNVD |
Cancer | 20164919 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Melanoma | 20877625 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:89460800-89521200 | Weak transcription | Stomach Smooth Muscle | stomach |
2 | chr3:89500800-89532400 | Weak transcription | Fetal Brain Female | brain |
3 | chr3:89501400-89521600 | Weak transcription | Brain Germinal Matrix | brain |
4 | chr3:89504000-89519800 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
5 | chr3:89506600-89527800 | Weak transcription | Ganglion Eminence derived primary cultured neurospheres | brain |
6 | chr3:89509000-89517000 | Weak transcription | Fetal Stomach | stomach |
7 | chr3:89515800-89516200 | Active TSS | ES-I3 Cell Line | embryonic stem cell |
8 | chr3:89515800-89516200 | Active TSS | iPS-15b Cell Line | embryonic stem cell |
9 | chr3:89515800-89516200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
10 | chr3:89516200-89516600 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
11 | chr3:89516200-89516800 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
12 | chr3:89516600-89517200 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
13 | chr3:89516600-89517600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
14 | chr3:89516800-89517200 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
15 | chr3:89516800-89517400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
16 | chr3:89516800-89517400 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
17 | chr3:89516800-89517600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
18 | chr3:89517000-89517200 | Enhancers | Fetal Muscle Leg | muscle |
19 | chr3:89517000-89517400 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
20 | chr3:89517000-89517400 | Enhancers | Fetal Stomach | stomach |
21 | chr3:89517200-89527600 | Weak transcription | Fetal Muscle Leg | muscle |
22 | chr3:89517400-89523400 | Weak transcription | Fetal Stomach | stomach |